Summary of "Лучшая добавка ДЛЯ КАЖДОГО МУЖЧИНЫ, который ходит в зал (эффективность доказана наукой)"

Key wellness / fitness strategies mentioned

Use the supplement only alongside a strict training + diet routine
- The speaker repeatedly states the “maximum effect” comes only when workouts and nutrition are disciplined.
- If someone “eats everything” and relies on the supplement alone, they won’t gain lean mass or burn fat as expected.
Target body composition goals (fat loss + lean muscle)
- Claims fat loss is accelerated by activating mitochondria and increasing fat oxidation.
- Notes an increased appetite effect (via ghrelin) to help those who struggle to eat enough during muscle-gain (“mass gaining”) phases.
Support recovery and strength growth
- Describes a mechanism where increased ghrelin leads to higher somatotropic hormone and insulin-like growth factor.
- Claims this improves recovery and strength growth similarly to growth hormone.
Injury prevention / joint & bone support
- Claims improved bone mineralization (via higher FR1) and stronger ligaments/joints.
- Aims to reduce injury risk when training with heavier weights.
Post-cycle use
- Suggests it may help preserve muscle mass after finishing “steroid-type drugs” (post-cycle period).

Effect duration: about 8 hours
Best times:
- After a workout
- Before bed
Weekly training frequency guidance:
- 5x/week: take regularly after workouts
- 3x/week: take after training and during rest periods, plus before bed

Start: 10 mg
Adjustment: if there are no positive effects but no side effects, increase to 20–25 mg
Upper limit: do not exceed the recommended dose (speaker warns of growth-hormone-like negative effects).

Body swelling
Carpal tunnel syndrome
Possible irreversible enlargement of ears/eyebrows (framed by the speaker as growth in uncovered bone zones)

The speaker cites studies claiming:
- 8-week use: increased dry muscle mass by ~3 kg and increased growth hormone in blood
- Longer-term use (elderly): growth hormone reportedly returned toward levels seen in younger people
- A 2022 study involving children with growth hormone deficiency (details referred to in the speaker’s Telegram)

Presenter: Denis Sorokin
Source referenced: studies of “Ibmaren/Ibotamaren” (specific papers not named in the subtitles)
Additional source mentioned: speaker’s Telegram (link referenced)